gimli

ELANTAS stock AI analysis

ELANTAS Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

ELANTAS BECK INDIA LTD. is a small-cap stock in Chemicals. This Gimli page shows the latest available ELANTAS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive ELANTAS stock page

Price

₹9,532.00

1W return

+0.75%

1M return

-10.24%

3M return

+2.99%

6M return

n/a

1Y return

n/a

Market cap

₹n/a

n/a

ROE

+15.76%

ROCE

n/a

RSI

45.54

Turnover

₹1.49 cr

Why it can matter in screens

Momentum: ELANTAS is below 50DMA, below 200DMA; RSI is 45.54.
Returns: 1D +2.72%, 1W +0.75%, 1M -10.24%, 3M +2.99%, 1Y n/a.
Trend levels: 52W high ₹10,755.00, 52W low ₹9,034.00, off high -11.37%.
Liquidity: latest turnover is ₹1.49 cr; volume vs 20D is +1.41%.
Valuation/profitability: PE n/a, PB n/a, ROE +15.76%, ROCE n/a.
Growth: 3Y sales CAGR +2.99%, 3Y profit CAGR +3.32%.

Quick Answers

What is the latest ELANTAS stock price?

The latest stored price for ELANTAS is Rs 9,532.00 as of 2026-07-20.

Is ELANTAS above its 50DMA and 200DMA?

ELANTAS is below 50DMA, below 200DMA. The latest 50DMA is 9,726.14 and the latest 200DMA is n/a.

What are ELANTAS PE, ROE and ROCE?

ELANTAS has PE n/a, ROE +15.76%, and ROCE n/a in Gimli's latest available snapshot.

How has ELANTAS performed recently?

ELANTAS has returned -10.24% over 1 month, +2.99% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	222.17 cr	46.31 cr	31.08 cr	39.21
2025-12-31	215.20 cr	58.81 cr	39.37 cr	49.66
2025-09-30	n/a	54.38 cr	n/a	45.74
2025-06-30	209.93 cr	58.10 cr	39.29 cr	49.56
2025-03-31	206.13 cr	49.03 cr	32.87 cr	41.46
2024-12-31	196.97 cr	45.03 cr	29.74 cr	nan

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2025-12-31	845.90 cr	220.32 cr	147.78 cr	186.41
2025-03-31	895.94 cr	220.32 cr	147.78 cr	186.41
2024-12-31	746.01 cr	199.14 cr	139.56 cr	176.05
2024-03-31	803.28 cr	199.14 cr	139.56 cr	176.05
2023-12-31	677.70 cr	196.09 cr	137.30 cr	173.18

Balance sheet

Period	Assets	Cash	Debt	Equity
2025-12-31	1,166.37 cr	65.97 cr	n/a	1,008.21 cr
2024-12-31	1,015.34 cr	139.62 cr	n/a	867.12 cr
2023-12-31	880.53 cr	3.23 cr	n/a	731.99 cr
2022-12-31	717.49 cr	5.86 cr	n/a	598.60 cr

Cash flow

Period	OCF	FCF	Cash change
2025-12-31	127.11 cr	96.23 cr	n/a
2024-12-31	63.22 cr	-81.92 cr	n/a
2023-12-31	133.42 cr	121.06 cr	n/a
2022-12-31	82.95 cr	75.53 cr	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SOLARINDS	SOLAR INDUSTRIES (I) LTD	172,184.56 cr	102.640495	+30.27%	+27.65%
PIDILITIND	PIDILITE INDUSTRIES LTD	159,363.26 cr	64.932529	+23.37%	+5.87%
SRF	SRF LTD	85,118.91 cr	46.381778	+13.76%	-9.90%
LINDEINDIA	LINDE INDIA LIMITED	59,669.09 cr	108.694787	+13.58%	+4.37%
COROMANDEL	COROMANDEL INTERNTL. LTD	59,544.89 cr	30.625989	+15.97%	-12.57%
FACT	FACT LTD	53,784.62 cr	-1358.197592	-2.91%	-12.86%
UPL	UPL LIMITED	51,160.88 cr	25.825785	+5.01%	-11.76%
FLUOROCHEM	GUJARAT FLUOROCHEM LTD	47,413.46 cr	82.030202	+7.60%	+23.34%

Try these prompts

Analyze ELANTAS BECK INDIA. with valuation, momentum and industry peers
Compare ELANTAS with other Chemicals stocks
Show small-cap stocks in Chemicals above 50DMA with positive 1M return
Find Chemicals stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-20. Not investment advice.